COYA
Coya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.20
−1.18%Margins
Gross margin
99.9%
EBITDA margin
-275.2%
EBIT margin
-282.3%
Net margin
-270.2%
FCF margin
—
-50.1%
Return on equity
-45.8%
Return on assets
-52.3%
Return on invested capital
0.16x
Asset turnover
-$13.7B
Cash from operations
$1.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026